<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72135">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01836042</url>
  </required_header>
  <id_info>
    <org_study_id>GTS100-PAS</org_study_id>
    <nct_id>NCT01836042</nct_id>
  </id_info>
  <brief_title>Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort</brief_title>
  <official_title>Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent System In Conjunction With Cataract Surgery: Extended Follow-up of the Premarket Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glaukos Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glaukos Corporation</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the long-term safety of the Glaukos® iStent®
      Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos
      Study GC-003.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Rate of sight-threatening adverse events</measure>
    <time_frame>80 Month average</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The primary endpoint is the occurrence of sight-threatening adverse events. The rate of sight-threatening adverse events at each visit will be calculated for the three treatment groups (randomized control group, randomized iStent group, and non-randomized iStent group) separately.  The summary will also be performed for pooling the randomized iStent and non-randomized iStent group.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">255</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Randomized iStent</arm_group_label>
    <description>Implantation of one iStent in conjunction with cataract surgery, patients randomized to group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized cataract surgery</arm_group_label>
    <description>Cataract surgery alone, patients randomized to group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-randomized iStent</arm_group_label>
    <description>Implantation of one iStent in conjunction with cataract surgery, patients not randomized to group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Extended follow-up of subjects previously enrolled in Glaukos Study GC-003
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects previously enrolled in Glaukos Study GC-003 who are able and willing to
             participate in this extended follow-up study

        Exclusion Criteria:

          -  Subjects previously enrolled in Glaukos Study GC-003 who are not able or willing to
             participate in this extended follow-up study

          -  Patients not previously enrolled in Glaukos Study GC-003
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Wells, PharmD, MBA</last_name>
    <role>Study Director</role>
    <affiliation>Glaukos Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jay Katz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Wills Eye Institute; Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silke Thode, PhD</last_name>
    <phone>949-367-9600</phone>
    <email>sthode@glaukos.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeff Wells, PharmD, MBA</last_name>
    <phone>949-367-9600</phone>
    <email>jwells@glaukos.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Petaluma</city>
        <state>California</state>
        <zip>94954</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>San Clemente</city>
        <state>California</state>
        <zip>92673</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Maria</city>
        <state>California</state>
        <zip>93454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Parker</city>
        <state>Colorado</state>
        <zip>80134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Morrow</city>
        <state>Georgia</state>
        <zip>30260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Independence</city>
        <state>Missouri</state>
        <zip>64055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Brookville</city>
        <state>Pennsylvania</state>
        <zip>15825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <zip>77702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Thode</last_name>
      <phone>949-367-9600</phone>
      <email>sthode@glaukos.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>December 16, 2013</lastchanged_date>
  <firstreceived_date>April 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary open-angle glaucoma (POAG)</keyword>
  <keyword>Trabecular meshwork</keyword>
  <keyword>iStent</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
